Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients

ObjectiveWe aimed to present our single-center real-life experience of canakinumab use in adult patients with familial Mediterranean fever (FMF).MethodsData were derived from the Gazi FMF cohort, which was established in 2010. From that year, all patients with FMF were registered. The impact of FMF